The high-end vaccine company was investigated for insider transactions, and the blue camp has a dark history. Tsai Ing-wen is required to come forward to clarify
China Jingwei.com reported that according to Taiwanese media reports, high-end, a biotechnology company that developed Taiwan’s self-produced vaccines, and its parent company, Kia,